IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Processa Pharmaceuticals Inc (PCSA)

CUSIP: 74275C403 | NYSE | Healthcare · Biotechnology | Micro Cap | 19 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GSoleus Capital Group, LLC160,9435.8%New 5%+ stakeAug 3, 2026No 13F filer matched
13D/AHX Entertainment Ltd305,64413.0%New 5%+ stakeFeb 13, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC31,252
0.0% of portfolio›$51.3K
UBS Group AG6,774
0.0% of portfolio›$11.1K
FMR LLC6
0.0% of portfolio›$10
Barclays PLC3
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Geode Capital Management, LLC
31,252$51.3K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
6,774$11.1K0.0%CoreMediumZurich, Switzerland2026-11-10
FMR LLC
6$100.0%GrowthMediumBoston, MA2026-11-10
Barclays PLC
3$50.0%GrowthMediumLondon, United Kingdom2026-11-06
No 13F filer matched
13GSoleus Capital Group, LLC160,943
5.8% of class · Aug 3, 2026New 5%+ stake
No 13F filer matched
13D/AHX Entertainment Ltd305,644
13.0% of class · Feb 13, 2026New 5%+ stake
No 13F filer matched